A nonsense mutation in the myophosphorylase gene in a Japanese family with McArdle's disease

Neuromuscular Disorders

Volumn 9, Issue 1, 1999, Pages 34-37

  Bruno, Claudio ^a   Tamburino, Lucia ^a   Kawashima, Noriko ^c   Andreu, Antonio L ^a,b   Shanske, Sara ^a   Hadjigeorgiou, George M ^a   Kawashima, Atsushi ^c   DiMauro, Salvatore ^a  

^a The New York Presbyterian Hospital   (United States)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c SAPPORO CITY GENERAL HOSPITAL   (Japan)

Author keywords

McArdle's disease; Myophosphorylase gene; Nonsense mutation

Indexed keywords

GLYCOGEN PHOSPHORYLASE; TRYPTOPHAN;

AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CLINICAL FEATURE; ELECTROMYOGRAPHY; FEMALE; GENETIC HETEROGENEITY; GENOME; GLYCOGEN STORAGE DISEASE TYPE 5; HUMAN; HUMAN TISSUE; MALE; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PEDIGREE; POINT MUTATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STOP CODON;

AGED; FEMALE; GLYCOGEN STORAGE DISEASE TYPE V; HUMANS; JAPAN; MALE; MIDDLE AGED; MOLECULAR BIOLOGY; MUTATION, MISSENSE; PEDIGREE; PHOSPHORYLASES; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0033036142     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(98)00096-0     Document Type: Article

References (13)

1. DiMauro S, Servidei S, Tsujino S. Disorders of carbohydrate metabolism: glycogen storage disease. In: The molecular and genetic basis of neurological disease. Third edition. Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL, editors. Boston: Butterworth-Heinemann, 1997:201-235.
2. Tsujino S, Shanske S, DiMauro S. Molecular heterogeneity of myophosphorylase deficiency (McArdle's disease). N Engl J Med 1993; 329:241-245.
3. Sugie H, Sugie Y, Ito M, Fukuda T, Nonaka I, Igarashi Y. Genetic analysis of Japanese patients with myophosphorylase deficiency (McArdle's disease): single codon deletion in exon 17 is the predominant mutation. Clin Chim Acta 1995;236:81-86.
4. Bruno C, Minetti C, Shanske S, et al. Combined defects of muscle phosphofructokinase and AMP deaminase in a child with myoglobinuria. Neurology 1998;50:296-298.
5. Tsujino S, Shanske S, Nonaka I, et al. Three new mutations in patients with myophosphorylase deficiency (McArdle's disease). Am J Hum Genet 1994;54:44-52.
6. Kubish C, Wicklein EM, Jentsch TJ. Molecular diagnosis of McArdle's disease: revised genomic structure of the myophosphorylase gene and identification of a novel mutation. Hum Mutat 1998;12: 27-32.
7. El-Schahawi M, Tsujino S, Shanske S, DiMauro S. Diagnosis of McArdle's disease by molecular genetic analysis of blood. Neurology 1996;47:579-580.
8. Bartram C, Edwards RHT, Clague J, Beynon RJ. McArdle's disease: a nonsense mutation in exon 1 of the muscle glycogen phosphorylase gene explains some but not all cases. Hum Mol Genet 1993;2:1291-1293.
9. Vorgerd M, Kubish C, Burwinkel B, et al. Mutation analysis in myophosphorylase deficiency (McArdle's disease). Ann Neurol 1998;43:326-331.
10. Martinuzzi A, Tsujino S, Vergani L, et al. Molecular characterization of myophosphorylase deficiency in a group of patients from Northern Italy. J Neurol Sci 1996;137:14-19.
11. Andreu AL, Bruno C, Gamez J, et al. Molecular genetic analysis of McArdle's disease in Spanish patients. Neurology 1998;51:260-262.
12. Hudson JW, Golding GB, Crerar MM. Evolution of allosteric control in glycogen phosphorylase. J Mol Biol 1993;234:700-721.
13. Tsujino S, Shanske S, Goto Y, Nonaka I, DiMauro S. Two mutations, one novel and one frequently observed, in Japanese patients with McArdle's disease. Hum Mol Genet 1994;3:1005-1006.